Illinois prisoners to get $80 million mental health boost

Caitlin Wilson | | Health Exec | Policy & Regulations

Illinois is set to spend $80 million on providing mental health services for 11,000 prisoners at four facilities in the state.

The money will be split in half—$40 million to pay for new facilities and $40 million for clinical and security staff, according to Think Progress.

The money is coming from the settlement of a class action lawsuit filed by prisoners who felt their mental health was poorly managed with “arbitrary” and “haphazard” standards that saw unreliable medication distribution and left some prisoners in solitary confinement instead of treatment.

Check out the story at Think Progress to read more about the new plan. 

After Nine-Year Battle, Illinois Will Provide 11,000 Prisoners With Mental Heal…

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Related Content

Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
Advancing AI for vascular surgery will require a commitment to data integrity

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.